Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

60275 1492790397HCLSReviewGreeceApril2017.pdf
Energy Boardroom

Baxter to spin off its $6B biopharma business in industry's latest split-up

27.03.2014 / Fierce Pharma

The pharma split-up movement is spreading. Baxter International says it will spin off its biopharma business into a separate company, leaving its $9 billion medical products business to venture on under the Baxter name.

Cover_HCLS_GREECE LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: